| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (DKO) / (WT) | Abundance Ratio: (SKO) / (WT) | Abundance Ratio (log2): (DKO) / (WT) | Abundance Ratio (log2): (SKO) / (WT) | Abundance Ratio P-Value: (DKO) / (WT) | Abundance Ratio P-Value: (SKO) / (WT) | Abundance Ratio Adj. P-Value: (DKO) / (WT) | Abundance Ratio Adj. P-Value: (SKO) / (WT) | Abundances (Grouped): DKO | Abundances (Grouped): SKO | Abundances (Grouped): WT | Abundances (Grouped) CV [%]: DKO | Abundances (Grouped) CV [%]: SKO | Abundances (Grouped) CV [%]: WT | Abundances (Scaled): F1: 127C, Sample, DKO, 1 | Abundances (Scaled): F1: 128C, Sample, DKO, 2 | Abundances (Scaled): F1: 129C, Sample, DKO, 3 | Abundances (Scaled): F1: 130C, Sample, DKO, 4 | Abundances (Scaled): F1: 129N, Sample, SKO, 1 | Abundances (Scaled): F1: 130N, Sample, SKO, 2 | Abundances (Scaled): F1: 131, Sample, SKO, 3 | Abundances (Scaled): F1: 126, Sample, WT, 1 | Abundances (Scaled): F1: 127N, Sample, WT, 2 | Abundances (Scaled): F1: 128N, Sample, WT, 3 | Abundances (Normalized): F1: 127C, Sample, DKO, 1 | Abundances (Normalized): F1: 128C, Sample, DKO, 2 | Abundances (Normalized): F1: 129C, Sample, DKO, 3 | Abundances (Normalized): F1: 130C, Sample, DKO, 4 | Abundances (Normalized): F1: 129N, Sample, SKO, 1 | Abundances (Normalized): F1: 130N, Sample, SKO, 2 | Abundances (Normalized): F1: 131, Sample, SKO, 3 | Abundances (Normalized): F1: 126, Sample, WT, 1 | Abundances (Normalized): F1: 127N, Sample, WT, 2 | Abundances (Normalized): F1: 128N, Sample, WT, 3 | Abundance: F1: 127C, Sample, DKO, 1 | Abundance: F1: 128C, Sample, DKO, 2 | Abundance: F1: 129C, Sample, DKO, 3 | Abundance: F1: 130C, Sample, DKO, 4 | Abundance: F1: 129N, Sample, SKO, 1 | Abundance: F1: 130N, Sample, SKO, 2 | Abundance: F1: 131, Sample, SKO, 3 | Abundance: F1: 126, Sample, WT, 1 | Abundance: F1: 127N, Sample, WT, 2 | Abundance: F1: 128N, Sample, WT, 3 | Abundances Count: F1: 127C, Sample, DKO, 1 | Abundances Count: F1: 128C, Sample, DKO, 2 | Abundances Count: F1: 129C, Sample, DKO, 3 | Abundances Count: F1: 130C, Sample, DKO, 4 | Abundances Count: F1: 129N, Sample, SKO, 1 | Abundances Count: F1: 130N, Sample, SKO, 2 | Abundances Count: F1: 131, Sample, SKO, 3 | Abundances Count: F1: 126, Sample, WT, 1 | Abundances Count: F1: 127N, Sample, WT, 2 | Abundances Count: F1: 128N, Sample, WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | P14483 | "H-2 class II histocompatibility antigen, A beta chain OS=Mus musculus OX=10090 GN=H2-Ab1 PE=1 SV=1" | 0 | 48.121 | 32 | 7 | 15 | 7 | 265 | 30.1 | 7.24 | 0.64 | 0.833 | -0.64 | -0.26 | 0.712705727 | 0.467169915 | 0.999945597 | 0.977211324 | 77.7 | 101 | 121.3 | 48.49 | 9.87 | 5.89 | 150.1 | 52.9 | 66.9 | 84.7 | 97.9 | 111.9 | 92.6 | 118.8 | 106.6 | 117.5 | 464.6 | 163.8 | 207 | 262 | 303 | 346.3 | 286.7 | 367.7 | 329.8 | 363.7 | 361.8 | 141 | 184.4 | 226.6 | 282.9 | 282.1 | 286.7 | 336 | 290.6 | 335.5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | regulation of biological process;response to stimulus | cell surface;endosome;Golgi;membrane | protein binding | "Pf00969, Pf07654, Pf08205" | 14961 | H2-Ab1 | 17 | MHC class II antigen presentation; Translocation of ZAP-70 to Immunological synapse; Phosphorylation of CD3 and TCR zeta chains; Downstream TCR signaling; PD-1 signaling; Generation of second messenger molecules | ENSMUSG00000073421.5 | Herpes simplex infection; Staphylococcus aureus infection; Rheumatoid arthritis; Allograft rejection; Toxoplasmosis; Tuberculosis; Cell adhesion molecules (CAMs); HTLV-I infection; Intestinal immune network for IgA production; Inflammatory bowel disease (IBD); Phagosome; Graft-versus-host disease; Influenza A; Viral myocarditis; Antigen processing and presentation; Type I diabetes mellitus; Systemic lupus erythematosus; Leishmaniasis; Hematopoietic cell lineage; Th1 and Th2 cell differentiation; Autoimmune thyroid disease; Asthma | 0 |